Royal Bank of Canada’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-72
Closed -$1K 7706
2024
Q2
$1K Sell
72
-128
-64% -$2.33K ﹤0.01% 6951
2024
Q1
$4K Hold
200
﹤0.01% 6553
2023
Q4
$2K Hold
200
﹤0.01% 6860
2023
Q3
$1K Hold
200
﹤0.01% 6985
2023
Q2
$1K Sell
200
-140,428
-100% -$855K ﹤0.01% 7134
2023
Q1
$557K Buy
140,628
+140,428
+70,214% +$619K ﹤0.01% 3781
2022
Q4
$1K Hold
200
﹤0.01% 7115
2022
Q3
$1K Hold
200
﹤0.01% 7320
2022
Q2
$1K Hold
200
﹤0.01% 7247
2022
Q1
$1K Hold
200
﹤0.01% 7639
2021
Q4
$2K Hold
200
﹤0.01% 7438
2021
Q3
$2K Buy
+200
New +$2.9K ﹤0.01% 7378
2018
Q4
Sell
-100
Closed -$3K 7215
2018
Q3
$3K Buy
100
+54
+117% +$1.62K ﹤0.01% 6452
2018
Q2
$1K Buy
+46
New +$1.26K ﹤0.01% 6409

Other funds holding MOR

Royal Bank of Canada's MOR Position: Q3 2024 in Review

Royal Bank of Canada sold out of MorphoSys AG American Depositary Shares (MOR) in Q3 2024, closing a stake of 72 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in MOR in Q2 2018 and held it in 14 quarters. The position peaked at $557K in Q1 2023. 9 funds tracked by Wall St. Rank hold MOR as of Q3 2024.

  • Royal Bank of Canada reported no remaining MorphoSys AG American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 72 MorphoSys AG American Depositary Shares shares in Q3 2024, an estimated $1K.
  • Royal Bank of Canada first reported a position in MorphoSys AG American Depositary Shares in Q2 2018 and held it in 14 quarters.
  • Royal Bank of Canada's MorphoSys AG American Depositary Shares position peaked at $557K in Q1 2023.
  • 9 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.